Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets

Detalles Bibliográficos
Autores principales: Singh, Anurag Kumar, Mishra, Gaurav, Maurya, Anand, Kulkarni, Giriraj T., Awasthi, Rajendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Letter to Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320859/
https://www.ncbi.nlm.nih.gov/pubmed/32758895
http://dx.doi.org/10.1016/j.mehy.2020.110059
_version_ 1783551331777118208
author Singh, Anurag Kumar
Mishra, Gaurav
Maurya, Anand
Kulkarni, Giriraj T.
Awasthi, Rajendra
author_facet Singh, Anurag Kumar
Mishra, Gaurav
Maurya, Anand
Kulkarni, Giriraj T.
Awasthi, Rajendra
author_sort Singh, Anurag Kumar
collection PubMed
description
format Online
Article
Text
id pubmed-7320859
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-73208592020-06-29 Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets Singh, Anurag Kumar Mishra, Gaurav Maurya, Anand Kulkarni, Giriraj T. Awasthi, Rajendra Med Hypotheses Letter to Editors Elsevier Ltd. 2020-11 2020-06-27 /pmc/articles/PMC7320859/ /pubmed/32758895 http://dx.doi.org/10.1016/j.mehy.2020.110059 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to Editors
Singh, Anurag Kumar
Mishra, Gaurav
Maurya, Anand
Kulkarni, Giriraj T.
Awasthi, Rajendra
Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets
title Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets
title_full Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets
title_fullStr Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets
title_full_unstemmed Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets
title_short Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets
title_sort biofabrication: an interesting tool to create in vitro model for covid-19 drug targets
topic Letter to Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320859/
https://www.ncbi.nlm.nih.gov/pubmed/32758895
http://dx.doi.org/10.1016/j.mehy.2020.110059
work_keys_str_mv AT singhanuragkumar biofabricationaninterestingtooltocreateinvitromodelforcovid19drugtargets
AT mishragaurav biofabricationaninterestingtooltocreateinvitromodelforcovid19drugtargets
AT mauryaanand biofabricationaninterestingtooltocreateinvitromodelforcovid19drugtargets
AT kulkarnigirirajt biofabricationaninterestingtooltocreateinvitromodelforcovid19drugtargets
AT awasthirajendra biofabricationaninterestingtooltocreateinvitromodelforcovid19drugtargets

Ejemplares similares